English | Español

Regulatory
+ Regulatory
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients
+ Technology/Innovation
Nicholas Gueguen | Jun 29, 2017

Study suggests ways to improve autism behaviors
+ Community
Nicholas Gueguen | Jun 29, 2017

Improved therapies, new medicines upping the chance cancer patients will live longer
+ Regulatory
Robert Hadley | Jun 29, 2017

Amgen hoping to extend use of Xgeva to prevent fractures in myeloma patients
+ Technology/Innovation
LocalLabs News Service | Jun 29, 2017

AbbVie says support program may benefit arthritis patients
+ Community
Ruth de Jauregui | Jun 28, 2017

Dungarvin Ohio acquires autism support services provider
+ Technology/Innovation
Robert Hadley | Jun 28, 2017

Pradaxa study highlights need for early diagnosis of atrial fibrillation
+ Regulatory
Robert Hadley | Jun 28, 2017

Pfizer a step closer to making $17B gamble on biosimilars pay off

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes